News and Events
October 17, 2019
If you plan to attend the upcoming 2019 AABB Annual Meeting being held in San Antonio, Texas, look out for these contributions from ICTMG:
Poster presentation: Fetal and Neonatal Alloimmune Thrombocytopenia: A systematic review and meta-analysis of the impact of HLA-DRB3*01:01 on neonatal outcome in HPA-1a immunized women. To read the poster abstract, visit: https://aabb.confex.com/aabb/2019/meetingapp.cgi/Paper/6359.
Educational session: ICTMG members Dr. Nadine Shehata, Dr. Richard Kaufman, and Dr. Cynthia So-Osman are speakers in the educational session, Evidence Based Guidelines: Toward Optimizing and Standardizing Transfusion Care. For more about their presentations, visit: https://aabb.confex.com/aabb/2019/meetingapp.cgi/Session/3273.
Seminar: ICTMG member Dr. Nadine Shehata will discuss the ICTMG “Red cell specifications for patients with hemoglobinopathies” systematic review and guideline at the Blood Group Genotyping Seminar.
To view the full schedule for the 2019 AABB Annual Meeting, visit http://www.aabb.org/annual-meeting/Pages/default.aspx
September 20, 2019
On July 19, 2019, the American Society of Hematology (ASH) affirmed that the "Red blood cell specifications for patients with hemoglobinopathies: a systematic review" and the "Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach" guidelines have value for hematologists. The guideline panel that developed them included an ASH representative, and the final guidelines were reviewed by the Guideline Oversight Subcommittee and Committee on Quality. ASH did not otherwise have input into the development of these guidelines.
June 27, 2019
ICTMG is excited to share its Fetal Neonatal and Alloimmune Thrombocytopenia (FNAIT) resources for patients and physicians. Visit the FNAIT page under Guideline Topics for podcasts, patient pamphlets, algorithms, a Powerpoint slide deck, and the guideline.
March 19, 2019
Get involved in the March 2019 insightScope Crowdsourcing Event!
The goal of this event is to help International Collaboration for Transfusion Medicine Guidelines (ICTMG) collaboration to rapidly complete a large systematic review. During this event, a large number of insightScope members (“the crowd”) will help the ICTMG to complete screening for a systematic review on the use of albumin for patients in the intensive care unit, patients with kidney failure and patients with liver failure. The ICTMG will use the results of the systematic review to develop guidelines for the optimum use of albumin.
February 27, 2019
The Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) guideline will be featured in an upcoming ISBT newsletter. See March 2019 (issue 118) of Transfusion Today.
November 1, 2018
Fetal neonatal alloimmune thrombocytopenia (FNAIT): Guidance to reduce the risk of intracranial bleeding” has been accepted as a poster presentation at the 2018 American Society of Hematology (ASH) Annual Meeting December 1-4 in San Diego, California, US.